Pathos is a clinical-stage, AI-enabled precision oncology biotech. We’re building the next generation of biopharma, where drug development is driven by AI and Multimodal patient data, not guesswork. With the largest Multimodal Foundation Model in Oncology as a backbone, we're running an integrated engine that pairs model-driven hypotheses with biological validation and biomarker-driven clinical execution, so the right therapies reach the right patients sooner.
| Website | https://www.pathos.com/ |
| Employees | 94 (52 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Oncology Therapeutics, Precision Oncology, Personalized Medicine, Innovative Cancer Therapies, Clinical Stage Drug Development, Biopharmaceutical Development, Pharmaceutical Partnerships, Targeted Cancer Therapy, Molecular Oncology, Drug Licensing, Cancer Biomarkers, Co-Development, Cancer Research, Drug Discovery, Clinical Trials, Cancer Treatment |
Looking for a particular Pathos employee's phone or email?
Matthew de Silva is the COO of Pathos.
52 people are employed at Pathos.